GeneType published in PLOS ONE – development of polygenic risk scores for cardiovascular diseases and type 2 diabetes MELBOURNE, Australia, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline-driven genomics-based tests in health,...

Webinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious disease MELBOURNE, Australia, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies (ASX:GTG, NASDAQ:GENE), a global leader in guideline driven Genomics based tests in health, wellness and serious disease...

Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer MELBOURNE, Australia, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and...

GeneType Risk Assessment Test onboarding in 16 clinics MELBOURNE, Australia, July 01, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...

New Zealand Rock Band 'Like A Storm' Making Their Mark on U.S. Billboard Chart LOS ANGELES, CA--(Marketwire - December 4, 2009) - LSI -- New Zealand natives Like A Storm, fresh off a stateside tour with Grammy winners Creed, are turning heads with their debut album "The End Of...